Please wait

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

(Name of Issuer)

(Title of Class of Securities)

(CUSIP Number)

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

SCHEDULE 13D/A 0001912273 XXXXXXXX LIVE 2 Common Stock, par value $0.01 per share 10/21/2025 false 0000718937 852312305 STAAR SURGICAL CO 1911 WALKER AVE MONROVIA CA 91016 Christopher Min Fang Wang 852 37933457 Unit 3703, 37/F AIA Tower 183 Electric Road, North Point Hong Kong K3 00000 Douglas Freeman, Esq. 852 3658 5328 Goodwin Procter (Hong Kong) LLP, 38 Flr Edinburgh Twr, 15 Queen's Road Central Hong Kong K3 00000 Leonard Wood, Esq. 1 212 459 7058 Goodwin Procter LLP, The NYT Building 620 Eighth Avenue New York NY 10018 Y Yunqi Path Capital Master Fund b WC N E9 0.00 2500061.00 0.00 2500061.00 2500061.00 N 5.1 CO 0001912273 N Yunqi Capital Limited b AF N K3 0.00 2500061.00 0.00 2500061.00 2500061.00 N 5.1 CO IA Y Yunqi Capital Cayman Limited b AF N E9 0.00 2500061.00 0.00 2500061.00 2500061.00 N 5.1 CO Y Christopher Min Fang Wang b AF N Z4 0.00 2500061.00 0.00 2500061.00 2500061.00 N 5.1 IN HC Common Stock, par value $0.01 per share STAAR SURGICAL CO 1911 WALKER AVE MONROVIA CA 91016 This Amendment No. 2 amends the statement on Schedule 13D filed by Yunqi Capital Limited and other Reporting Persons on September 22, 2025, as amended on October 7, 2025 (the "Schedule 13D"). Item 4 is hereby amended and supplemented by the addition of the following: On October 21, 2025 (Hong Kong time), the Reporting Persons issued via press release (the "Third Press Release") an open letter to the board of directors of the Issuer further discussing the Reporting Persons' continued intention to vote against the Proposed Merger. The Third Press Release addresses the Reporting Persons' concerns about recent disclosures of the Issuer, urges the Issuer to hold its special meeting of stockholders on October 23, 2025, and discusses the Issuer's preliminary net sales results for third quarter 2025. The foregoing description is qualified by reference to the full text of the Third Press Release, which is attached as Exhibit E to this Schedule 13D. Item 7 is hereby amended to add the following exhibit: Exhibit E: Press Release, dated October 21, 2025 Yunqi Path Capital Master Fund /s/ Christopher Min Fang Wang Christopher Min Fang Wang / Director 10/21/2025 Yunqi Capital Limited /s/ Christopher Min Fang Wang Christopher Min Fang Wang / Director 10/21/2025 Yunqi Capital Cayman Limited /s/ Christopher Min Fang Wang Christopher Min Fang Wang / Director 10/21/2025 Christopher Min Fang Wang /s/ Christopher Min Fang Wang Christopher Min Fang Wang 10/21/2025